Strong Revenue Growth:
Revenue and test volumes are rising, with 2025 total revenue up year over year to $147.2M, U.S. Galleri revenue up, and more than 185,000 tests sold; quarterly updates also showed double‑digit growth.
Strategic Partnerships:
Access expanded through TRICARE coverage, Quest Diagnostics ordering integration, digital‑health channels, and health‑system/EHR integrations, alongside international collaborations such as Samsung and a Canada launch.
Investor Backing & Capital Strength:
Funding raised in 2025 and a reported cash balance exceeding $850M provide runway into 2030, supporting continued commercialization and regulatory efforts.
